CAS 2095719-92-7

(R)-2-(6-(5-Chloro-2-((tetrahydro-2H-pyran-4-yl)amino)pyrimidin-4-yl)-1-oxoisoindolin-2-yl)-N-((S)-1-(3-fluoro-5-methoxyphenyl)-2-hydroxyethyl)propanamide

CAS: 2095719-92-7

Formula: C₂₉H₃₁ClFN₅O₅

Purity: 99%

Color and Shape: Solid

Molecular weight: 584.0383

Ref: IN-DA01LIB0

ERK1/2 inhibitor 2

CAS: 2095719-92-7

ERK1/2 inhibitor 2

Purity: ≥98%

Molecular weight: 584.04g/mol

Ref: 54-BUP04263

ERK1/2 inhibitor 2

CAS: 2095719-92-7

ERK1/2 inhibitor 2 (ASTX029) is a selective and orally bioavailable ERK 1/2 inhibitor, with potential antineoplastic activity.

Formula: C₂₉H₃₁ClFN₅O₅

Purity: 98.99%

Color and Shape: Solid

Molecular weight: 584.04

Ref: TM-T8472

Erk1/2 inhibitor 2

CAS: 2095719-92-7

Erk1/2 inhibitor 2 is a selective small molecule inhibitor designed to target and inhibit the activity of the extracellular signal-regulated kinases 1 and 2 (Erk1/2). These kinases are critical components of the mitogen-activated protein kinase (MAPK) signaling pathway, which is integral to regulating various cellular processes, including proliferation, differentiation, and survival. The source of Erk1/2 inhibitor 2 is synthetic, produced through meticulous organic synthesis techniques specifically tailored to enhance its selectivity and potency.

Formula: C₂₉H₃₁ClFN₅O₅

Purity: Min. 95%

Molecular weight: 584 g/mol

Ref: 3D-VID71992